Inspire Medical Systems Inc (INSP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($52.47 Million) by net assets ($781.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inspire Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Inspire Medical Systems Inc debt and liabilities for a breakdown of total debt and financial obligations.
Inspire Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inspire Medical Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Companhia Siderúrgica Nacional
SA:CSNA3
|
0.023x |
|
Bk Harda Internasional Tbk Pt
JK:BBHI
|
0.052x |
|
Zhejiang Jiahua Energy Chemical Industry Co Ltd
SHG:600273
|
0.025x |
|
Gansu Jiu Steel Group Hongxing Iron & Steel Co Ltd
SHG:600307
|
0.101x |
|
Transmissora Aliança de Energia Elétrica S.A
SA:TAEE3
|
0.086x |
|
Charter Hall Retail REIT
AU:CQR
|
0.038x |
|
Siltronic AG
XETRA:WAF
|
0.027x |
|
German American Bancorp Inc
NASDAQ:GABC
|
0.006x |
Annual Cash Flow Conversion Efficiency for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Inspire Medical Systems Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $781.16 Million | $116.98 Million | 0.150x | -20.70% |
| 2024-12-31 | $689.70 Million | $130.25 Million | 0.189x | +338.55% |
| 2023-12-31 | $572.51 Million | $24.65 Million | 0.043x | +84.62% |
| 2022-12-31 | $496.01 Million | $11.57 Million | 0.023x | +126.55% |
| 2021-12-31 | $229.05 Million | $-20.12 Million | -0.088x | +61.96% |
| 2020-12-31 | $229.75 Million | $-53.05 Million | -0.231x | +3.27% |
| 2019-12-31 | $139.84 Million | $-33.38 Million | -0.239x | -109.40% |
| 2018-12-31 | $164.00 Million | $-18.69 Million | -0.114x | +98.93% |
| 2017-12-31 | $1.48 Million | $-15.79 Million | -10.641x | -491.75% |
| 2016-12-31 | $-6.61 Million | $-17.95 Million | 2.716x | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more